Furthermore, increasing concentrations of crizotinib inhibited the expression of long intergenic noncoding RNA regulator of reprogramming (linc-ROR) which plays a role in acquiring and maintaining CSCs as well as chemoresistance in NSCLC [81]. The gene discussed is LINC-ROR; the disease is non-small cell lung carcinoma.